Loading clinical trials...
Loading clinical trials...
The purpose with this study is to test a digital patient-provider communication tool for symptom and needs management among patients with chronic health conditions.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Oslo University Hospital
Collaborators
NCT07090512 · Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation
NCT03726307 · Kidney Transplant, Renal Transplant Recipients
NCT02115503 · Renal Transplant Recipients With Anti-HLA Antibodies
NCT01283542 · Non-functioning Pituitary Adenoma
NCT00991510 · Stable Renal Transplant Recipients
Oslo University hospital
Oslo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions